Percentage Identity and Biotechnological Patents: The Battle Over the Scope of Protection
By Ana Herrera Arroyo, head of Patents, Technological Development and Innovation at PONS IP In modern biotechnology, few issues generate as much debate during patent prosecution and validity proceedings as claims directed to biological sequences defined by percentage identity. For any applicant, claiming only a specific sequence is often commercially inadequate: competitors may introduce minor … Read more